Navigation Links
New Jersey Health Foundation President Addresses Panel at AAHC Research Efficiency Conference
Date:1/8/2014

NEW BRUNSWICK, N.J., Jan. 8, 2014 /PRNewswire-USNewswire/ -- James M. Golubieski, president of New Jersey Health Foundation (NJHF) and Foundation Venture Capital Group (FVCG), discussed how these organizations promote the commercialization of research in New Jersey as he addressed a panel at the Research Efficiency Conference in Washington, DC, sponsored by the Association of Academic Health Centers.

At a session "Looking Beyond the NIH" that explored alternate funding sources, Mr. Golubieski discussed the unique model of New Jersey Health Foundation and Foundation Venture Capital Group and how they are helping scientists and universities to keep pace with a quickly moving research environment that has begun to emphasize commercialization as a means of advancing research.

"The fact that we are independent not-for-profit organizations allows us to invest in research at an early stage, providing start-up companies with the financial and strategic support they need to move their research to the next level," Mr. Golubieski explained to the group. 

New Jersey Health Foundation (www.njhf.org) is an independent organization supporting academic research and education programs at universities in New Jersey.  An investment of $10 million to fund its affiliate, Foundation Venture Capital Group (www.foundationventure.com), has allowed FVCG to invest in 10 start up companies with investments of up to $500,000 each.   One company was sold within 18 months at a substantial return on investment.  FVCG is currently selecting 10 more companies for investment.   

The Association of Academic Health Centers (www.aahcdc.org) is a non-profit organization that seeks to advance the nation's health and well-being through vigorous leadership of the nation's academic health centers.

"As economic pressures on research have intensified, the investments by funders like the New Jersey Health Foundation and Foundation Venture Capital Group add important viability to the overall research enterprise," said Dr. Steven A. Wartman, AAHC president and CEO.

In addition to Foundation Venture Capital Group, NJHF operates two other programs to support research in New Jersey.  Its Research Awards Program has granted more than $54 million to researchers in early stages of work since inception of the program.  A new program, Innovation Stage Funding Program, has awarded grants to researchers with promising ideas that may lead to developing patents or intellectual property.

About New Jersey Health Foundation
New Jersey Health Foundation (www.njhf.org) is a not-for-profit corporation that supports biomedical research and health-related education programs in New Jersey through its matching program, its Grants Program and its affiliate, Foundation Venture Capital Group (www.foundationventure.com) which makes private equity investments in life science start- up companies headed toward commercialization in New Jersey.


'/>"/>
SOURCE New Jersey Health Foundation
Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. Custom Metal Fabricators of Stainless Steel Tanks and Components to Attend ISPE New Jersey Chapter 2013 Supplier Showcase and Tabletop Show
2. JTB Law Group, LLC Featured in New Jersey Legal Leaders, Top Rated Lawyers for 2013
3. Renowned New Jersey Plastic Surgeon Dr. Fred Coville Receives Prestigious Speaking Honor
4. Visiting Nurse Association of Northern New Jersey Announces Gardening Program at Friendship House Adult Day Care
5. Black Data Processing Associates (BDPA) New Jersey Hosts 10th Annual Families in Technology Day June 8, 2013
6. Reproductive Medicine Associates of New Jersey Receives ACOG Prize for Paper on SET and CCS, a Pioneering IVF Process
7. Choose New Jersey and Partners to Promote New Jersey As Global Life Science Hub at Worlds Largest Biotechnology Event
8. Masy Systems Increases Validation Personnel in Pennsylvania and New Jersey
9. IntelliCell BioSciences Announces Research Agreement with the New Jersey Center for Biomaterials at Rutgers-The State University of New Jersey
10. New Egg Donation Program, "Ovatures," Launched By Reproductive Medicine Associates Of New Jersey
11. Allergan Opens New Research and Development Center in Bridgewater, New Jersey
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/24/2017)... On Thursday, March 23, 2017, ... down 0.07%; the Dow Jones Industrial Average edged 0.02% ... closed at 2,345.96, marginally dropping 0.11%. US markets saw ... 4 sectors finished in red, and 1 sector ended ... reports coverage on the following Biotechnology equities: BioDelivery Sciences ...
(Date:3/23/2017)... (PRWEB) , ... March 23, 2017 , ... ... viscoelastic material that exhibits both viscous and elastic characteristics when deformed, which is ... polymer exhibits properties to gently absorb compressive forces and return to its natural ...
(Date:3/23/2017)... March 23, 2017  Northwest Biotherapeutics (OTCQB: NWBO) ... immune therapies for solid tumor cancers, today announced ... financing it announced last Friday, March 17, 2017. ... institutional investors securities totaling 28,843,692 shares, comprised of ... 10,000,000 shares of Class C Warrants pre-funded at ...
(Date:3/23/2017)... MENLO PARK, Calif., March 23, 2017  BioPharmX ... developing products for the dermatology market, today reported ... Jan. 31, 2017, and will provide an update ... from the year. "We are pleased ... productive year for BioPharmX," said President Anja Krammer. ...
Breaking Biology Technology:
(Date:3/2/2017)... -- Summary This report provides all the information ... and activities since 2010. ... Read the full report: http://www.reportlinker.com/p03605615-summary/view-report.html ... provides an in-depth insight into the partnering activity of one ... demand company reports are prepared upon purchase to ensure inclusion ...
(Date:3/2/2017)... Australian stem cell and regenerative medicine company, ... an agreement with the Monash Lung Biology Network, a ... and Department of Pharmacology at Monash University, ... to support the use of Cymerus™ mesenchymal stem cells ... Asthma is a chronic, long term lung condition recognised ...
(Date:2/28/2017)... , February 28, 2017 News solutions ... ... Amsterdam from 14 to 16 March, Materna will ... and show how seamless travel is a real benefit for passengers. ... added biometrics to their passenger touch point solutions to take passengers ...
Breaking Biology News(10 mins):